{"id":"doi:10.1016/j.ctrv.2017.11.007","kind":"review","title":"CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy","authors":["Ryuma Tokunaga","Wu Zhang","Madiha Naseem","Alberto Puccini","Martin D. Berger","Shivani Soni","Michelle McSkane","Hideo Baba","Heinz‐Josef Lenz"],"author_count":9,"year":2017,"published":"2017-11-26","venue":"Cancer Treatment Reviews","cited_by":1625,"doi":"10.1016/j.ctrv.2017.11.007","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.ctrv.2017.11.007","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.ctrv.2017.11.007","updated":null,"pmid":"29207310","pmcid":null,"openalex_id":"W2770893462","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Chemokine receptors and signaling"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}